4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-26-032561
Chief Medical Officer sold 51,880 shares at $2.05 ($106,536)
- Chief Medical Officer acquired 131,167 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Jones Mitchell Lawrence · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-06 | Exercise or conversion : show line 1 in the form | +131,167 | 145,889 | D | ||
| 2026-07-07 | Sale : show line 2 in the form | −51,880 | $2.05 | $106,536 | 94,009 | D |
| Open-market sales · 51,880 sh · avg $2.05 · $106,536 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-06 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −131,167 | 655,833 | D |
Loading xslF345X06/ownership.xml…